198 related articles for article (PubMed ID: 35457141)
1. AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia.
Gonçalves-Alves E; Garcia M; Rodríguez-Hernández CJ; Gómez-González S; Ecker RC; Suñol M; Muñoz-Aznar O; Carcaboso AM; Mora J; Lavarino C; Mateo-Lozano S
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457141
[TBL] [Abstract][Full Text] [Related]
2. Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens.
Rodríguez-Hernández CJ; Mateo-Lozano S; García M; Casalà C; Briansó F; Castrejón N; Rodríguez E; Suñol M; Carcaboso AM; Lavarino C; Mora J; de Torres C
Oncotarget; 2016 Mar; 7(13):16112-29. PubMed ID: 26893368
[TBL] [Abstract][Full Text] [Related]
3. Divergent effects of strontium and calcium-sensing receptor positive allosteric modulators (calcimimetics) on human osteoclast activity.
Diepenhorst NA; Leach K; Keller AN; Rueda P; Cook AE; Pierce TL; Nowell C; Pastoureau P; Sabatini M; Summers RJ; Charman WN; Sexton PM; Christopoulos A; Langmead CJ
Br J Pharmacol; 2018 Nov; 175(21):4095-4108. PubMed ID: 29714810
[TBL] [Abstract][Full Text] [Related]
4. Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics.
Cook AE; Mistry SN; Gregory KJ; Furness SG; Sexton PM; Scammells PJ; Conigrave AD; Christopoulos A; Leach K
Br J Pharmacol; 2015 Jan; 172(1):185-200. PubMed ID: 25220431
[TBL] [Abstract][Full Text] [Related]
5. Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody.
Makita N; Ando T; Sato J; Manaka K; Mitani K; Kikuchi Y; Niwa T; Ootaki M; Takeba Y; Matsumoto N; Kawakami A; Ogawa T; Nangaku M; Iiri T
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996138
[TBL] [Abstract][Full Text] [Related]
6. Novel strategies in drug discovery of the calcium-sensing receptor based on biased signaling.
Thomsen AR; Smajilovic S; Bräuner-Osborne H
Curr Drug Targets; 2012 Sep; 13(10):1324-35. PubMed ID: 22702634
[TBL] [Abstract][Full Text] [Related]
7. Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
Babinsky VN; Hannan FM; Gorvin CM; Howles SA; Nesbit MA; Rust N; Hanyaloglu AC; Hu J; Spiegel AM; Thakker RV
J Biol Chem; 2016 May; 291(20):10876-85. PubMed ID: 26994139
[TBL] [Abstract][Full Text] [Related]
8. Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor.
Davey AE; Leach K; Valant C; Conigrave AD; Sexton PM; Christopoulos A
Endocrinology; 2012 Mar; 153(3):1232-41. PubMed ID: 22210744
[TBL] [Abstract][Full Text] [Related]
9. Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption.
Lee JJ; Liu X; O'Neill D; Beggs MR; Weissgerber P; Flockerzi V; Chen XZ; Dimke H; Alexander RT
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31013259
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological characteristics of drugs targeted on calcium-sensing receptor.-properties of cinacalcet hydrochloride as allosteric modulator].
Nagano N; Tsutsui T
Clin Calcium; 2016 Jun; 26(6):839-50. PubMed ID: 27230839
[TBL] [Abstract][Full Text] [Related]
11. Recent updates on the calcium-sensing receptor as a drug target.
Trivedi R; Mithal A; Chattopadhyay N
Curr Med Chem; 2008; 15(2):178-86. PubMed ID: 18220773
[TBL] [Abstract][Full Text] [Related]
12. Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders.
Nemeth EF; Shoback D
Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):373-84. PubMed ID: 23856266
[TBL] [Abstract][Full Text] [Related]
13. Allosteric modulation and G-protein selectivity of the Ca
He F; Wu CG; Gao Y; Rahman SN; Zaoralová M; Papasergi-Scott MM; Gu TJ; Robertson MJ; Seven AB; Li L; Mathiesen JM; Skiniotis G
Nature; 2024 Feb; 626(8001):1141-1148. PubMed ID: 38326620
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.
Henley C; Yang Y; Davis J; Lu JY; Morony S; Fan W; Florio M; Sun B; Shatzen E; Pretorius JK; Richards WG; St Jean DJ; Fotsch C; Reagan JD
J Pharmacol Exp Ther; 2011 Jun; 337(3):681-91. PubMed ID: 21422163
[TBL] [Abstract][Full Text] [Related]
15. Activation of calcium-sensing receptor by allosteric agonists cinacalcet and AC-265347 abolishes the 1,25(OH)
Wongdee K; Rodrat M; Keadsai C; Jantarajit W; Teerapornpuntakit J; Thongbunchoo J; Charoenphandhu N
Arch Biochem Biophys; 2018 Nov; 657():15-22. PubMed ID: 30217510
[TBL] [Abstract][Full Text] [Related]
16. Sensing Extracellular Calcium - An Insight into the Structure and Function of the Calcium-Sensing Receptor (CaSR).
Chavez-Abiega S; Mos I; Centeno PP; Elajnaf T; Schlattl W; Ward DT; Goedhart J; Kallay E
Adv Exp Med Biol; 2020; 1131():1031-1063. PubMed ID: 31646544
[TBL] [Abstract][Full Text] [Related]
17. Calcium-sensing receptor activation attenuates collagen expression in renal proximal tubular epithelial cells.
Wu M; Feng Y; Ye GX; Han YC; Wang SS; Ni HF; Wang FM; Gao M; Lv LL; Liu BC
Am J Physiol Renal Physiol; 2019 May; 316(5):F1006-F1015. PubMed ID: 30838870
[TBL] [Abstract][Full Text] [Related]
18. Personalised medicines for familial hypercalcemia and hyperparathyroidism.
Josephs TM; Zhang F; Dinh LV; Keller AN; Conigrave AD; Capuano B; Gregory KJ; Leach K
J Mol Endocrinol; 2022 May; 69(1):243-257. PubMed ID: 35318962
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of the calcium sensing receptor.
Filopanti M; Corbetta S; Barbieri AM; Spada A
Clin Cases Miner Bone Metab; 2013 Sep; 10(3):162-5. PubMed ID: 24554924
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoperones and the calcium sensing receptor: exogenous and endogenous regulators.
Breitwieser GE
Pharmacol Res; 2014 May; 83():30-7. PubMed ID: 24291533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]